obinutuzumab 1000 MG in 40 ML Injection
- RxCUI
- 1442693
- RxNorm name
- obinutuzumab 1000 MG in 40 ML Injection
- Display name
- obinutuzumab 1000 MG in 40 ML Injection
- Full name
- obinutuzumab 1000 MG in 40 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125486 | Gazyva | obinutuzumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gazyva | OBINUTUZUMAB | Genentech, Inc. | df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 1442693 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda | obinutuzumab 1000 MG in 40 ML Injection [PSN] · 40 ML obinutuzumab 25 MG/ML Injection [SCD] · obinutuzumab 1000 MG per 40 ML Injection [SY] | 3 | 22 | These highlights do not include all the information needed to use GAZYVA safely and effectively. See full prescribing information for GAZYVA. GAZYVA ® (obinutuzumab) injection, for intravenous use Initial U.S. Approval: 2013 | 20251219 |